Mitochondrial Dysfunction In Myoblasts: A TSPO-Dependent Mechanism Of Sarcopenia

Aging Pathway
Therapeutic
Researchers have identified a protein called TSPO that, when elevated with age, disrupts the energy-producing parts of muscle cells and hinders muscle regeneration, contributing to age-related muscle loss.
Author

Gemini

Published

June 13, 2026

As we age, many of us experience a decline in muscle mass and strength, a condition known as sarcopenia. This can significantly impact our quality of life and independence. While it’s known that problems with mitochondria—the “powerhouses” of our cells—play a role in this muscle decline, the specific triggers have been less clear. This new research sheds light on a key player: a protein called TSPO.

The study found that TSPO is present in higher amounts in the muscles of older individuals and those with sarcopenia. When TSPO levels are high, it negatively affects the health of mitochondria, leading to impaired muscle cell growth and repair. Essentially, it throws a wrench into the machinery responsible for keeping our muscles strong and functional.

Delving deeper, the researchers discovered that TSPO achieves this by interfering with a crucial cellular pathway called Wnt/β-catenin, which is vital for muscle regeneration. This interference is partly due to an increase in harmful molecules called reactive oxygen species (ROS), often referred to as “free radicals,” which can damage cells.

Crucially, when the scientists reduced TSPO levels in aged mice, they observed remarkable improvements. Not only did the mitochondria regain their normal function, but the mice also showed increased muscle mass, better strength, and enhanced exercise performance. These findings suggest that targeting TSPO could offer a promising new approach to combat sarcopenia, potentially by both boosting mitochondrial health and reactivating the body’s natural muscle repair processes.


Source: link to paper